News

MELBOURNE, Australia & NANTES, France, 16 April 2018 – Telix announced a research partnership with...
Read More →
MELBOURNE, Australia, 10 April 2018 – Telix Pharmaceuticals is disclosing that a controlled entity of...
Read More →
MELBOURNE Australia, 28 March 2018 – Telix Pharmaceuticals is pleased to provide this update on the...
Read More →
MELBOURNE & INDIANAPOLIS,  26 March 2018 – Telix Pharmaceuticals announced the submission of a Drug...
Read More →
SYDNEY, April 4 2018 – Telix Pharmaceuticals gets a mention in the CLSA M&A Outlook for...
Read More →
MELBOURNE, Australia & NIJMEGAN, The Netherlands, March 15 2018 – Telix Pharmaceuticals Ltd has today...
Read More →
BioSpectrum Asia interviews Telix Japan President & COO Dr Shintaro Nishimura on APAC oncology market...
Read More →
Melbourne & Brussels March 1 2018 – Telix Pharmaceuticals Ltd has today announced the appointment of...
Read More →
Melbourne, Australia, Feb. 26 2018 – Telix Pharmaceuticals Limited is pleased to provide its Annual Report 2017,...
Read More →
Melbourne, Australia, Feb. 21 2018 – Telix Pharmaceuticals Limited is pleased to provide this shareholder...
Read More →